BioCentury
ARTICLE | Financial News

Halozyme completes debt financing

January 13, 2014 8:00 AM UTC

Halozyme Therapeutics Inc. (NASDAQ:HALO), San Diego, Calif. Business: Endocrine/Metabolic, Cancer, Dermatology Date completed: 1/6/14 Type: Debt financing Raised: $20 million Investors: Oxford Finance...